CVS, Aetna executives defend $69 billion deal to skeptical Wall Street
NEW YORK (Reuters) – CVS Health Corp and Aetna Inc top executives on Monday defended their planned merger to Wall Street analysts and investors who questioned the near-term impact on profits of the $69 billion deal to...
Read More